{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:31:00Z","timestamp":1771327860671,"version":"3.50.1"},"reference-count":33,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:p>\n          <jats:bold>OBJECTIVES<\/jats:bold> Iron deficiency anemia (IDA) is very common in children with inflammatory bowel disease (IBD). While health-related quality of life (HRQL) is a key outcome measure, no long-term studies have evaluated the effect of correction of IDA on HRQL in children with IBD. Our goal was to prospectively study changes in HRQL in iron-deficient children with IBD receiving routine iron supplementation with periodic intravenous iron sucrose (IVIS).<\/jats:p>\n        <jats:p>\n          <jats:bold>METHODS<\/jats:bold> Thirty-eight children with IBD treated with infliximab participated. Hematology and inflammatory markers were assessed before each infliximab treatment. Iron-deficient patients (transferrin saturation below 20% and\/or ferritin below 30 ng\/mL or 100 ng\/mL with normal or elevated C-reactive protein, respectively) received IVIS after each infliximab infusion until iron indices stayed normal for two consecutive measurements. HRQL was assessed with Pediatric Quality of Life Inventory every 4 months. Correlation between changes in mean hemoglobin levels and HRQL scores was analyzed prospectively in 3-month periods over a period exceeding 3 years.<\/jats:p>\n        <jats:p>\n          <jats:bold>RESULTS<\/jats:bold> At enrollment, 27 patients had already been established on infliximab; 11 had not started or completed induction. Mean iron indices and hemoglobin normalized after 3 and 6 month of starting IVIS, respectively. Multiple HRQL parameters significantly improved, regardless of the duration of infliximab treatment at the time of enrollment. There was a statistically significant positive correlation between correction of anemia and improvement in parent-reported emotional and physical HRQL scores.<\/jats:p>\n        <jats:p>\n          <jats:bold>CONCLUSIONS<\/jats:bold> Periodic IVIS resulted in long-term correction of IDA in children with IBD. Correction of IDA contributed to some improvements in HRQL.<\/jats:p>","DOI":"10.5863\/1551-6776-24.6.517","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:12:37Z","timestamp":1573060357000},"page":"517-527","source":"Crossref","is-referenced-by-count":4,"title":["Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation"],"prefix":"10.5863","volume":"24","author":[{"given":"Istvan","family":"Danko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy","family":"Weidkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens C.","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"11","key":"i1551-6776-24-6-517-b1","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"599","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","year":"2010","unstructured":"Stein\n              J\n            , HartmannF, DignassAU.\n          Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11):599\u2013610."},{"issue":"11\u201312","key":"i1551-6776-24-6-517-b2","series-title":"Aliment Pharmacol Ther","first-page":"1507","article-title":"Systematic review: managing anaemia in Crohn's disease","volume":"24","year":"2006","unstructured":"Kulnigg\n              S\n            , GascheC.\n          Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24(11\u201312):1507\u20131523."},{"issue":"3","key":"i1551-6776-24-6-517-b3","series-title":"Inflamm Bowel Dis","first-page":"513","article-title":"Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease","volume":"18","year":"2012","unstructured":"Goodhand\n              JR\n            , KamperidisN, RaoA, \n          et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(3):513\u2013519."},{"issue":"6","key":"i1551-6776-24-6-517-b4","series-title":"J Crohns Colitis","first-page":"687","article-title":"Anaemia and iron deficiency in children with inflammatory bowel disease","volume":"6","year":"2012","unstructured":"Wiskin\n              AE\n            , FlemingBJ, WoottonSA, \n          et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis. 2012;6(6):687\u2013691."},{"key":"i1551-6776-24-6-517-b5","series-title":"Annu Rev Nutr","first-page":"521","article-title":"Iron deficiency and cognitive function","volume":"13","year":"1993","unstructured":"Pollitt\n              E.\n            \n          \n          Iron deficiency and cognitive function. Annu Rev Nutr. 1993;13:521\u2013537."},{"issue":"10","key":"i1551-6776-24-6-517-b6","series-title":"Neuropsychiatr Dis Treat","first-page":"2087","article-title":"Iron deficiency and cognitive functions","volume":"10","year":"2014","unstructured":"Jauregui-Lobera\n              I.\n            \n          \n          Iron deficiency and cognitive functions. Neuropsychiatr Dis Treat. 2014;10(10):2087\u20132095."},{"issue":"4","key":"i1551-6776-24-6-517-b7","series-title":"J Pediatr Gastroenterol Nutr","first-page":"449","article-title":"Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"56","year":"2013","unstructured":"Mackner\n              LM\n            , GreenleyRN, SzigethyE, \n          et al. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2013;56(4):449\u2013458."},{"issue":"5","key":"i1551-6776-24-6-517-b8","series-title":"J Pediatr Gastroenterol Nutr","first-page":"539","article-title":"F-calprotectin and blood markers correlate to quality of life in pediatric inflammatory bowel disease","volume":"65","year":"2017","unstructured":"Carlsen\n              K\n            , JakobsenC, KallemoseT, \n          et al. F-calprotectin and blood markers correlate to quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2017;65(5):539\u2013545."},{"issue":"2","key":"i1551-6776-24-6-517-b9","series-title":"Inflamm Bowel Dis","first-page":"123","article-title":"Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients","volume":"12","year":"2006","unstructured":"Wells\n              CW\n            , LewisS, BartonJR, \n          et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12(2):123\u2013130."},{"issue":"6","key":"i1551-6776-24-6-517-b10","series-title":"Inflamm Bowel Dis","first-page":"1450","article-title":"Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease","volume":"22","year":"2016","unstructured":"Herrera-deGuise\n              C\n            , CasellasF, RoblesV, \n          et al. Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(6):1450\u20131455."},{"issue":"3","key":"i1551-6776-24-6-517-b11","series-title":"Semin Pediatr Neurol","first-page":"158","article-title":"Iron deficiency and brain development","volume":"13","year":"2006","unstructured":"Lozoff\n              B\n            , GeorgieffMK.\n          Iron deficiency and brain development. Semin Pediatr Neurol. 2006;13(3):158\u2013165."},{"issue":"5","key":"i1551-6776-24-6-517-b12","series-title":"Israel Med Assoc J","first-page":"335","article-title":"Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia","volume":"10","year":"2008","unstructured":"Pinsk\n              V\n            , LevyJ, MoserA, \n          et al. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. Israel Med Assoc J. 2008;10(5):335\u2013338."},{"issue":"11","key":"i1551-6776-24-6-517-b13","series-title":"Am J Gastroenterol","first-page":"2503","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014a randomized, controlled, open-label, multicenter study","volume":"100","year":"2005","unstructured":"Schroder\n              O\n            , MickischO, SeidlerU, \n          et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100(11):2503\u20132509."},{"issue":"50","key":"i1551-6776-24-6-517-b14","series-title":"J Crohns Colitis","first-page":"566","article-title":"Serum hepcidin and iron absorption in paediatric inflammatory bowel disease","volume":"10","year":"2016","unstructured":"Martinelli\n              M\n            , StrisciuglioC, AlessandrellaA, \n          et al. Serum hepcidin and iron absorption in paediatric inflammatory bowel disease. J Crohns Colitis. 2016;10(50):566\u2013574."},{"issue":"2","key":"i1551-6776-24-6-517-b15","series-title":"Haematologica","first-page":"175","article-title":"Pathogenesis and treatment of anemia in inflammatory bowel disease","volume":"95","year":"2010","unstructured":"Weiss\n              G\n            , GascheC.\n          Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95(2):175\u2013178."},{"issue":"7","key":"i1551-6776-24-6-517-b16","series-title":"Scand J Gastroenterol","first-page":"838","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in ibd patients: a randomized, controlled, evaluator-blind, multicentre study","volume":"44","year":"2009","unstructured":"Lindgren\n              S\n            , WikmanO, BefritsR, \n          et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in ibd patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44(7):838\u2013845."},{"issue":"9","key":"i1551-6776-24-6-517-b17","series-title":"Scand J Gastroenterol","first-page":"1027","article-title":"Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life","volume":"48","year":"2013","unstructured":"Befrits\n              R\n            , WikmanO, BlomquistL, \n          et al. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scand J Gastroenterol. 2013;48(9):1027\u20131032."},{"key":"i1551-6776-24-6-517-b18","series-title":"Gastroenterol Res Pract","article-title":"The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency","volume":"2015","year":"2015","unstructured":"Cekic\n              C\n            , IpekS, AslanF, \n          et al. The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract. 2015;2015:582163. doi:10.1155\/2015\/582163."},{"issue":"5","key":"i1551-6776-24-6-517-b19","series-title":"Dig Dis","first-page":"444","article-title":"Intravenous iron replacement improves quality of life in hypoferritinemic inflammatory bowel disease patients with and without anemia","volume":"35","year":"2017","unstructured":"Eliadou\n              E\n            , KiniG, HuangJ, \n          et al. Intravenous iron replacement improves quality of life in hypoferritinemic inflammatory bowel disease patients with and without anemia. Dig Dis. 2017;35(5):444\u2013448."},{"issue":"4","key":"i1551-6776-24-6-517-b20","series-title":"Arq Gastroenterol","first-page":"255","article-title":"Treatment of anemia and improvement of quality of life among patients with Crohn's disease: experience using ferric carboxymaltose","volume":"52","year":"2015","unstructured":"Sobrado\n              CW\n            , CancadoRD, SobradoLF, \n          et al. Treatment of anemia and improvement of quality of life among patients with Crohn's disease: experience using ferric carboxymaltose. Arq Gastroenterol. 2015;52(4):255\u2013259."},{"issue":"2","key":"i1551-6776-24-6-517-b21","series-title":"J Pediatr Pharmacolo Ther","first-page":"162","article-title":"Response of iron deficiency anemia to intravenous iron sucrose in pediatric inflammatory bowel disease","volume":"21","year":"2016","unstructured":"Danko\n              I.\n            \n          \n          Response of iron deficiency anemia to intravenous iron sucrose in pediatric inflammatory bowel disease. J Pediatr Pharmacolo Ther. 2016;21(2):162\u2013168."},{"issue":"5","key":"i1551-6776-24-6-517-b22","series-title":"J Pediatr Gastroenterol Nutr","first-page":"e107","article-title":"Correction of iron deficiency anemia with intravenous iron sucrose in children with inflammatory bowel disease","volume":"63","year":"2016","unstructured":"Danko\n              I\n            , WeidkampM.\n          Correction of iron deficiency anemia with intravenous iron sucrose in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;63(5):e107\u2013e111."},{"issue":"4","key":"i1551-6776-24-6-517-b23","series-title":"Br J Clin Pharmacol","first-page":"694","article-title":"Safety and efficacy of parenteral iron in children with inflammatory bowel disease","volume":"84","year":"2018","unstructured":"Papadopoulos\n              M\n            , PatelD, Korologou-LindenR, \n          et al. Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Br J Clin Pharmacol. 2018;84(4):694\u2013699."},{"issue":"2","key":"i1551-6776-24-6-517-b24","series-title":"J Pediatr Gastroenterol Nutr","first-page":"e51","article-title":"Intravenous iron sucrose for treatment of iron deficiency anemia in pediatric inflammatory bowel disease","volume":"66","year":"2018","unstructured":"Stein\n              RE\n            , PlantzK, MaxwellEC, \n          et al. Intravenous iron sucrose for treatment of iron deficiency anemia in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2018;66(2):e51\u2013e55."},{"issue":"3","key":"i1551-6776-24-6-517-b25","series-title":"J Crohns Colitis","first-page":"211","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","year":"2015","unstructured":"Dignass\n              AU\n            , GascheC, BettenworthD, \n          et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211\u2013222."},{"issue":"4","key":"i1551-6776-24-6-517-b26","series-title":"J Pediatr Gastroenterol Nutr","first-page":"439","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"12","year":"1991","unstructured":"Hyams\n              JS\n            , FerryGD, MandelFS, \n          et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439\u2013447."},{"issue":"2","key":"i1551-6776-24-6-517-b27","series-title":"Gastroenterology","first-page":"423","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","year":"2007","unstructured":"Turner\n              D\n            , OtleyAR, MackD, \n          et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133(2):423\u2013432."},{"issue":"6","key":"i1551-6776-24-6-517-b28","series-title":"Ambul Pediatr","first-page":"329","article-title":"The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity","volume":"3","year":"2003","unstructured":"Varni\n              JW\n            , BurwinkleTM, SeidM, \n          et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329\u2013341."},{"issue":"8","key":"i1551-6776-24-6-517-b29","series-title":"Med Care","first-page":"800","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","year":"2001","unstructured":"Varni\n              JW\n            , SeidM, KurtinPS.\n          PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u2013812."},{"issue":"9","key":"i1551-6776-24-6-517-b30","series-title":"J Pediatr Psychol","first-page":"983","article-title":"Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology","volume":"33","year":"2008","unstructured":"Palermo\n              TM\n            , LongAC, LewandowskiAS, \n          et al. Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol. 2008;33(9):983\u2013996; discussion 997\u2013998."},{"issue":"1","key":"i1551-6776-24-6-517-b31","series-title":"Child Health Care","first-page":"29","article-title":"Health-related quality of life in children and adolescents with inflammatory bowel disease","volume":"36","year":"2007","unstructured":"Cunningham\n              C\n            , DrotarD, PalermoTM, \n          et al. Health-related quality of life in children and adolescents with inflammatory bowel disease. Child Health Care. 2007;36(1):29\u201343."},{"issue":"2","key":"i1551-6776-24-6-517-b32","series-title":"J Pediatr Gastroenterol Nutr","first-page":"164","article-title":"Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics","volume":"46","year":"2008","unstructured":"Perrin\n              JM\n            , KuhlthauK, ChughtaiA, \n          et al. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr. 2008;46(2):164\u2013171."},{"issue":"5","key":"i1551-6776-24-6-517-b33","series-title":"Inflamm Bowel Dis","first-page":"925","article-title":"Improved quality of life with anti-tnf therapy compared with continued corticosteroid utilization in Crohn's disease","volume":"25","year":"2019","unstructured":"Scott\n              FI\n            , JohnsonFR, BewtraM, \n          et al. Improved quality of life with anti-tnf therapy compared with continued corticosteroid utilization in Crohn's disease. Inflamm Bowel Dis. 2019;25(5):925\u2013936."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/6\/article-p517.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/24\/6\/517\/2466695\/1551-6776-24_6_517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/6\/article-p517.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/6\/article-p517.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:42:06Z","timestamp":1747356126000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/6\/article-p517.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":33,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-24.6.517","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}